MALAT1 and cancer: The downregulation of MALAT1 decreases TMZ resistance by reducing the expression level of ZEB1, an EMT-related protein that increases cancer cell motility and invasiveness (de Cremoux et al. 2007; Li et al. 2017; Dong et al. 2019).